explore -WSS

explore

author：explore 2025-10-02 19:20:56 - browse：6311

Sterile capsules for injection line up in a dispensing line — politics coverage from STAT — Adobe

WASHINGTON — The Senate Finance Committee has drafted a bipartisan bill to mitigate drug shortages by rewarding hospitals for business practices that ensure an adequate supply of drugs.

Drug shortages have been a persistent problem for years, and they’re worse than ever, according to a recent report by the American Society of Health-System Pharmacists. Shortages are primarily a problem for hospitals and doctors who regularly administer drugs, including oncologists who have been running out of common chemo drugs. Generic injectables account for 67% of shortages, and more than half of drugs in short supply cost less than $1 per unit, according to the Finance Committee.

Hospitals band together to negotiate drug prices by hiring group purchasing organizations. The biggest three GPOs are estimated to control about 90% of the market for drugs that hospitals buy. Finance Chair Ron Wyden (D-Ore.) said those GPOs can drive prices down so low that manufacturers stop making certain drugs or can’t afford to maintain their facilities, which then leads to manufacturing interruptions. Drugmakers also say GPOs can also be fickle, switching from one manufacturer to another over small savings, leaving drugmakers without the certainty they need to commit to making large volumes of product.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Gene therapy denied for Afghan refugee whose father aided U.S.

focus

WSS

Eli Lilly, Pfizer, and others want in on the online prescription market

Research misconduct: Proposed new rules face resistance

Prior authorization will have to move faster under new Biden rule

Think you might have Covid

Why doctors need education on FDA device approval process

Hospital chaplains balance Covid safety with patients’ spiritual needs

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The tragedy of Johnson & Johnson’s Covid vaccine

New air purifier tech could be key to improving indoor air quality

Medicare Advantage overpayments discussion gets experts fired up

Virginia high school admissions case could be legal follow

Stories you might have missed in 2023: health, science, medicine

Cancer drug shortages should be causing more outrage

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

ChatGPT in medicine: STAT answers readers' burning questions

American taxpayers paid $1.8 trillion in health care costs in 2022

focus

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

STAT Virtual Event: JPM Recap, Live!

Elizabeth Holmes banned from government health programs

Dewpoint Therapeutics lays off staff after losing partnerships

Dewpoint Therapeutics lays off staff after losing partnerships

FDA early review: GLP

focus

focus

entertainment

hotspot